Guidelines for Evaluating an Essential Drugs Programme: 8. PLANNING FOR THE FUTURE: 8.3 PROGRAMME STRATEGY

Guidelines for Evaluating an Essential Drugs Programme
(64 pages)

Table des matières

INTRODUCTION
PROCEDURES FOR EVALUATION OF AN ACTION PROGRAMME ON ESSENTIAL DRUGS (APED)
EXECUTIVE SUMMARY: OVERALL CONCLUSIONS AND RECOMMENDATIONS
1. SUMMARY BACKGROUND INFORMATION ON COUNTRY AND HEALTH CARE SYSTEM¹
2. BRIEF DESCRIPTION OF THE GENERAL FEATURES OF THE APED PROGRAMME
3. ECONOMIC AND SOCIOECONOMIC ASPECTS OF THE APED PROGRAMME
4. ANALYSIS OF EFFICIENCY
	4.1 SELECTION
		4.1.1 SELECTION OF DRUGS
		4.1.2 SELECTION OF ESSENTIAL EQUIPMENT AND DRESSINGS
	4.2 LOGISTICS
		4.2.1 PROCUREMENT
			A. PROCUREMENT METHOD
			B. CONTRACT TERMS
			C. LOCATING AND SELECTING SUPPLIERS
			D. PROCURING
			E. MONITORING SUPPLIER PERFORMANCE
			F. QUALITY ASSURANCE
			G. LOCAL PRODUCTION OF PHARMACEUTICALS OR IMPORT
		4.2.2 DISTRIBUTION
			H. RECEIVING AND INSPECTING
			I. STORAGE AND WAREHOUSING
			J. INVENTORY CONTROL
			K. SUPPLY
			L. DELIVERY
		4.2.3 LOGISTIC SUPPORT
			M. MAINTENANCE AND REPAIR
			N. ENVIRONMENTAL MANAGEMENT OF HEALTH FACILITIES
			O. RECORDS AND REPORTING
	4.3 MANPOWER DEVELOPMENT
		4.3.1 FORMAL TRAINING
		4.3.2 SUPERVISION
	4.4 HEALTH EDUCATION AND INFORMATION
	4.5 POLICY AND LEGAL ASPECTS
		4.5.1 POLICY
		4.5.2 LEGAL ASPECTS
5. ASSESSMENT OF EFFECTIVENESS
	5.1 AVAILABILITY OF DRUGS
	5.2 ACCESSIBILITY OF DRUGS
	5.3 PROPER USE OF DRUGS
	5.4 CLIENT SATISFACTION
	5.5 COMMUNITY INVOLVEMENT
	5.6 MEDICAL ASSESSMENT OF EFFECTIVENESS
6. MANAGING THE ESSENTIAL DRUG PROGRAMME
	6.1 PROGRAMME ORGANIZATION AND MANAGEMENT
		6.1.1 INTERNAL ORGANIZATION
		6.1.2 FINANCIAL MANAGEMENT
		6.1.3 DRUG SUPPLY SYSTEM
		6.1.4 HEALTH CARE DELIVERY SYSTEM
	6.2 BUDGETING, FINANCING AND COSTING
		6.2.1 PATTERNS OF HEALTH EXPENDITURE
		6.2.2 MANAGEMENT AND OPERATIONAL ASPECTS
		6.2.3 ASSESSING COSTS
	6.3 MONITORING
		6.3.1 INDICATORS
		6.3.2 PROCESSING AND ANALYSIS OF DATA
		6.3.3 PRESENTATION AND USE OF MONITORING RESULTS
7. ASSESSMENT OF INPUTS OF THE GOVERNMENT AND DONORS
	7.1 GOVERNMENT
	7.2 WORLD HEALTH ORGANIZATION
	7.3 DONOR(S)
	7.4 OTHER PARTICIPATING AGENCIES
8. PLANNING FOR THE FUTURE
	8.1 PROGRAMME PLANNING
	8.2 PROGRAMME OBJECTIVES
	8.3 PROGRAMME STRATEGY
	8.4 MANAGEMENT
	8.5 FEASIBILITY
	8.6 EXTERNAL ASSISTANCE
9. REFERENCES
MANUAL FOR CONDUCTING AN EVALUATION OF AIM ACTION PROGRAMME ON ESSENTIAL DRUGS (APED)
	I. PHASES AND STEPS OF AN APED EVALUATION
		A. INITIATION PHASE
		B. DESIGN PHASE
		C. ADMINISTRATIVE PREPARATION PHASE
		D. FIELD WORK PHASE
		E. ANALYSIS PHASE
		F. DOCUMENTATION PHASE
	II. TIMING
	ANNEX 1 SUGGESTED BUDGET FRAMEWORK
	ANNEX 2 TIMETABLE OF ACTIVITIES DURING THE EVALUATION

8.3 PROGRAMME STRATEGY

Will the strategy remain the same in the future, e.g., is there a need to shift the balance between the components or has one component been completed and therefore must be deleted, etc.?